about
New Immunosuppressive Therapies in Uveitis TreatmentMacrophages and Uveitis in Experimental Animal ModelsAn anti-interleukin-2 receptor drug attenuates T- helper 1 lymphocytes-mediated inflammation in an acute model of endotoxin-induced uveitisProspective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma.Photodynamic therapy for age-related macular degeneration treatment: epidemiological and clinical analysis of a long-term study.Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments.Image quality comparison of two multifocal IOLs: influence of the pupil.Excimer laser photorefractive keratectomy for high myopia.Direct objective quantification of corneal haze after excimer laser photorefractive keratectomy for high myopia.Ultraviolet radiation at Mediterranean latitudes and protection efficacy of intraocular lenses.Choroidal neovascularization after intraocular foreign body.Evaluation of automated image analysis software for the detection of diabetic retinopathy to reduce the ophthalmologists' workload.IL-2 and IFN-gamma in the retina of diabetic rats.Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type II.Effect of prophylactic brimonidine on bleeding complications after cataract surgery.Clinical magnification and residual refraction after implantation of a double intraocular lens system in patients with macular degeneration.Photoprotection and photoreception of intraocular lenses under xenon and white LED illumination.Light transmission and ultraviolet protection of contact lenses under artificial illumination.Electrophysiological and clinical tests in dry age-related macular degeneration follow-up: differences between mfERG and OCT.Lipoic acid lessens Th1-mediated inflammation in lipopolysaccharide-induced uveitis reducing selectively Th1 lymphocytes-related cytokines release.A rapid method for measuring intraocular lens power in vitro with a focimeter.Comparison of the acute effects of anti-TNF-alpha drugs on a uveitis experimental model.Looking into aqueous humor through metabolomics spectacles - exploring its metabolic characteristics in relation to myopia.Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre TrialThe 50th ISCEV international symposium abstract issueIn vitro test of intraocular lens biocompatibilityDiclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culturePosterior chamber silicone intraocular lens for the correction of myopia: an experimental study in rabbitsAcute iridocyclitis in a patient with AIDS diagnosed as toxoplasmosis by PCRIntravitreal injection of bevacizumab induces inflammatory alterations in a uveitis experimental modelOne-year follow-up of combined customized therapy. Photodynamic therapy and bevacizumab for exudative age-related macular degenerationMutation profile of the MYO7A gene in Spanish patients with Usher syndrome type ISpectral transmission of the human crystalline lens in adult and elderly persons: color and total transmission of visible lightImaging quality of bifocal piggyback intraocular lens versus ReSTOR and TECNIS multifocal lensesCombined therapy: photodynamic therapy and bevacizumab to treat myopic neovascular membranes. One-year follow-upSpectral transmission of the pig lens: effect of ultraviolet A+B radiationDetermination of scattering in intraocular lenses by spectrophotometric measurementsComputer-aided diagnosis software for hypertensive risk determination through fundus image processing
P50
Q26798201-05084481-0127-4A3E-9C0E-9C1E27141CA8Q26828497-A252BA33-2467-4255-A5E3-08332717D74FQ28540312-897EE37A-8E45-4649-AF7E-A7FDEECCA3BBQ33381446-5E60E6A6-CBDB-4BD4-819F-05329E6691F6Q33457364-C4FCE7D7-5D3C-4514-BCB8-E7831AB294C5Q34299469-21D939DA-7875-4EAB-A12C-7C79F21A5279Q35605320-4882EAF4-DC6C-48B9-8ADD-7A26CAFC4E63Q36786474-94748D27-24BA-4CF7-92E4-E0F32D6790D1Q36835316-8DA4E2E2-99C2-43C8-8D6C-44B451FD8866Q39120798-F2DBC3F2-7DB1-4659-8C01-6A884FB0B46CQ40022973-FF5C62B8-419F-4E40-A8B6-F6DB840D89D2Q40203818-EF187364-3800-44AD-BB60-A16E6A1D66E5Q43137697-1D900F4E-83D1-4CE9-A9B0-B3FCA5E21805Q43145971-DF9847FE-E2C2-49D5-9DD5-00329BDD033CQ46424101-24DFAE06-D9A9-4304-9FBF-43F946B29A68Q47385431-3AFF6744-6AE6-4547-B35D-D303CEA92A97Q47430753-841A3F89-50A8-4DFC-B43F-9069EFA3BAF0Q48930631-EA211130-30A6-40ED-B6EB-6B7DD740EFFDQ50203983-4F982ABA-AA72-4F99-A5F3-FEAD862FF50BQ50989771-617305A8-BFEC-4DA0-917A-70B6E32283AAQ51714678-EFCD4BD6-29AF-48B7-B38B-F8B7FC7032F8Q52600870-5FAFD6A0-2087-4FCE-A2CC-92811D83BE61Q53132795-954D9DA9-3554-4AB0-A96D-FCE820FD8A74Q58567790-4B4CE7C4-FD1A-4573-92E9-3721665BE2F0Q59571965-8840AD52-2935-46FC-8BC9-7F1511A60615Q72335183-52F85E14-0744-4FF0-AB0C-239F851FBA03Q73186758-0B11E6A7-E55B-44BC-8281-A393B1923FD0Q73393440-C6DE1596-16C7-48F1-8A75-0E5847EA7F2EQ74298249-9F0CBCFC-C650-4F49-BF15-3E6CD3BB48BAQ82248431-F6C22E7C-DD2C-4081-AF3C-B6BD8EE804A6Q82295444-50B72679-CDAB-4A64-B07D-59B8234E2528Q82521296-F8B0C95D-DCCC-415C-B3F9-302B151C422FQ83852599-6D7D7336-9C09-4390-992F-D219E9BD9867Q84829973-DDE5537C-2137-4041-B25D-6B6919738088Q85239830-D4F4682E-CDB4-42E7-AC0C-C4CE9481DEA7Q85675069-8B8EFD16-9A4A-48C8-9972-E8D28E775389Q86401396-9317F895-FD1C-4C86-8CE3-FE1D8F3FE9DEQ87403347-4855C9C9-5A95-4633-8F0A-FCEC05D13789
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Amparo Navea
@ast
Amparo Navea
@en
Amparo Navea
@es
Amparo Navea
@nl
Amparo Navea
@sl
type
label
Amparo Navea
@ast
Amparo Navea
@en
Amparo Navea
@es
Amparo Navea
@nl
Amparo Navea
@sl
prefLabel
Amparo Navea
@ast
Amparo Navea
@en
Amparo Navea
@es
Amparo Navea
@nl
Amparo Navea
@sl
P106
P31
P496
0000-0002-9856-5370